CASE STUDY Medicsight Inc. Brief Medicsight Inc’s business was to conceive, develop and commercialise innovative medical applications. It needed an independent opinion on the value of 15,000,000 Medicsight plc shares issued to Medicsight Inc in November 2001 and applied in settling an outstanding purchase consideration due to Nightingale Technologies Limited Approach A rigorous valuation report was complied under the provisions of SEC guidelines, US GAAP, the Uniform Standards of Professional Appraisal Practice and other relevant guidelines. The report also analysed the applicable standard of value, rights of the shares and appropriate methodologies. The report then analysed all relevant bases of valuation of the shares the underlying assets (intellectual property) or other releva

Join for free to read